Technical Analysis for ALDX - Aldeyra Therapeutics, Inc.

Grade Last Price % Change Price Change
grade C 6.08 -0.16% -0.01
ALDX closed down 0.16 percent on Wednesday, November 13, 2019, on 88 percent of normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Up Up
See historical ALDX trend table...

Date Alert Name Type % Chg
Bollinger Band Squeeze Range Contraction 0.00%
Calm After Storm Range Contraction 0.00%
BB Squeeze + Upper Band Touch Range Contraction 0.00%
Outside Day Range Expansion 0.00%
Upper Bollinger Band Touch Strength 0.00%
Bollinger Band Squeeze Range Contraction -0.16%
Calm After Storm Range Contraction -0.16%
BB Squeeze + Upper Band Touch Range Contraction -0.16%
Up 3 Days in a Row Strength -0.16%
Upper Bollinger Band Touch Strength -0.16%

Older signals for ALDX ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Aldeyra Therapeutics, Inc. (Aldeyra) is a biotechnology company. The Company is focused primarily on the development of products to treat immune-mediated, inflammatory, orphan, and other diseases that are thought to be related to a naturally occurring toxic chemical species known as free aldehydes. The Company is developing NS2. NS2 is a product candidate that is designed to trap and allow for disposal of free aldehydes, for the treatment of diseases, which include Sjogren-Larsson Syndrome (SLS), discoid lupus, acute anterior uveitis and ocular rosacea with meibomian gland dysfunction. Aldeyra is also developing aldehyde traps distinct from NS2. As of April 7, 2014, it had evaluated NS2 in a Phase I clinical trial in 48 volunteers.
Medicine Biotechnology Medical Specialties Diseases Organ Systems Autoimmune Diseases Rare Diseases Uveitis Inflammatory Syndromes Systemic Lupus Erythematosus
Is ALDX a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 1 bullish, 1 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 12.79
52 Week Low 4.31
Average Volume 229,606
200-Day Moving Average 6.6956
50-Day Moving Average 5.6607
20-Day Moving Average 5.875
10-Day Moving Average 5.932
Average True Range 0.3753
ADX 13.86
+DI 18.1991
-DI 16.3914
Chandelier Exit (Long, 3 ATRs ) 5.1741
Chandelier Exit (Short, 3 ATRs ) 6.196
Upper Bollinger Band 6.1652
Lower Bollinger Band 5.5848
Percent B (%b) 0.85
BandWidth 9.879149
MACD Line 0.1255
MACD Signal Line 0.1108
MACD Histogram 0.0147
Fundamentals Value
Market Cap 37.97 Million
Num Shares 6.25 Million
EPS -1.47
Price-to-Earnings (P/E) Ratio -4.14
Price-to-Sales 0.00
Price-to-Book 4.06
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 6.49
Resistance 3 (R3) 6.49 6.35 6.42
Resistance 2 (R2) 6.35 6.25 6.35 6.39
Resistance 1 (R1) 6.22 6.19 6.29 6.22 6.37
Pivot Point 6.08 6.08 6.12 6.08 6.08
Support 1 (S1) 5.95 5.98 6.02 5.95 5.79
Support 2 (S2) 5.81 5.92 5.81 5.77
Support 3 (S3) 5.68 5.81 5.74
Support 4 (S4) 5.68